Interleukin-31 stimulates production of inflammatory mediators from human colonic subepithelial myofibroblasts

International Journal of Molecular Medicine

Volumn 19, Issue 6, 2007, Pages 941-946

  Yagi, Yuhki ^a   Andoh, Akira ^a   Nishida, Atsushi ^a   Shioya, Makoto ^a   Nishimura, Takashi ^a   Hashimoto, Takayoshi ^a   Tsujikawa, Tomoyuki ^a   Saito, Yasuharu ^a   Fujiyama, Yoshihide ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Colonic myofibroblasts; Inflammatory mediators; Interleukin 31

Indexed keywords

AUTACOID; CYTOKINE; IL31 PROTEIN, HUMAN; INTERLEUKIN 17; INTERLEUKIN DERIVATIVE; MATRIX METALLOPROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; COLON; COMPARATIVE STUDY; DNA MICROARRAY; DRUG COMBINATION; DRUG EFFECT; FIBROBLAST; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTESTINE MUCOSA; METABOLISM; MYOBLAST; TH2 CELL;

CELLS, CULTURED; COLON; CYTOKINES; DRUG COMBINATIONS; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-17; INTERLEUKINS; INTESTINAL MUCOSA; MATRIX METALLOPROTEINASES; MYOBLASTS, SMOOTH MUSCLE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TH2 CELLS;

EID: 34548576938     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.19.6.941     Document Type: Article

References (36)

1. Podolsky DK: Inflammatory bowel disease. N Engl J Med 347: 417-429, 2002.
2. Hibi T and Ogata H: Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol 41: 10-16, 2006.
3. Loftus EV Jr: Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126: 1504-1517, 2004. (Pubitemid 38649869)
4. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, Haugen HS, Maurer M, Harder B, Johnston J, Bort S, Mudri S, Kuijper JL, Bukowski T, Shea P, Dong DL, Dasovich M, Grant FJ, Lockwood L, Levin SD, LeCiel C, Waggie K, Day H, Topouzis S, Kramer J, Kuestner R, Chen Z, Foster D, Parrish-Novak J and Gross JA: Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 5: 752-760, 2004.
5. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F and Graeve L: Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334: 297-314, 1998.
6. Ghilardi N, Li J, Hongo JA, Yi S, Gurney A and de Sauvage FJ: A novel type I cytokine receptor is expressed on monocytes, signals proliferation, and activates STAT-3 and STAT-5. J Biol Chem 277: 16831-16836, 2002. (Pubitemid 34967706)
7. Andoh A, Bamba S, Fujiyama Y, Brittan M and Wright NA: Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response. J Gastroenterol 40: 1089-1099, 2005. (Pubitemid 43124835)
8. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI and West AB: Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol 277: C183-C201, 1999.
9. Mahida YR, Beltinger J, Makh S, Goke M, Gray T, Podolsky DK and Hawkey CJ: Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2. Am J Physiol 273: G1341-G1348, 1997.
10. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI and West AB: Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 277: C1-C9, 1999.
11. Okuno T, Andoh A, Bamba S, Araki Y, Fujiyama Y, Fujiyama M and Bamba T: Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts. Scand J Gastroenterol 37: 317-324, 2002.
12. Frederiksen CM, Aaboe M, Dyrskjot L, Laurberg S, Wolf H, Orntoft TF and Kruhoffer M: Technical evaluation of cDNA microarrays. APMIS Suppl: 96-101, 2003.
13. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
14. Andoh A, Fujiyama Y, Sumiyoshi K, Sakumoto H and Bamba T: Interleukin 4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells. Gastroenterology 111: 911-918, 1996. (Pubitemid 26327593)
15. Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler GD, Altschul SF, Zeeberg B, Buetow KH, Schaefer CF, Bhat NK, Hopkins RF, Jordan H, Moore T, Max SI, Wang J, Hsieh F, Diatchenko L, Marusina K, Farmer AA, Rubin GM, Hong L, Stapleton M, Soares MB, Bonaldo MF, Casavant TL, Scheetz TE, Brownstein MJ, Usdin TB, Toshiyuki S, Carninci P, Prange C, Raha SS, Loquellano NA, Peters GJ, Abramson RD, Mullahy SJ, Bosak SA, McEwan PJ, McKernan KJ, Malek JA, Gunaratne PH, Richards S, Worley KC, Hale S, Garcia AM, Gay LJ, Hulyk SW, Villalon DK, Muzny DM, Sodergren EJ, Lu X, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madan A, Young AC, Shevchenko Y, Bouffard GG, Blakesley RW, Touchman JW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Krzywinski MI, Skalska U, Smailus DE, Schnerch A, Schein JE, Jones SJ and Marra MA: Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci USA 99: 16899-16903, 2002.
16. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM and Weaver CT: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132, 2005.
17. Bamba S, Andoh A, Yasui H, Araki Y, Bamba T and Fujiyama Y: Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17. J Gastroenterol 38: 548-554, 2003.
18. Hata K, Andoh A, Shimada M, Fujino S, Bamba S, Araki Y, Okuno T, Fujiyama Y and Bamba T: IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol 282: G1035-G1044, 2002.
19. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, Bamba T and Fujiyama Y: Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70, 2003. (Pubitemid 36020767)
20. Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, Araki Y, Tsujikawa T, Kitoh K, Kim-Mitsuyama S, Takayanagi A, Shimizu N and Fujiyama Y: Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129: 969-984, 2005.
21. Diveu C, Lak-Hal AH, Froger J, Ravon E, Grimaud L, Barbier F, Hermann J, Gascan H and Chevalier S: Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling. Eur Cytokine Netw 15: 291-302, 2004. (Pubitemid 40127653)
22. Papanicolaou DA, Wilder RL, Manolagas SC and Chrousos GP: The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128: 127-137, 1998.
23. Ito H, Takazoe M, Fukuda Y, Hibi T, Kusugami K, Andoh A, Matsumoto T, Yamamura T, Azuma J, Nishimoto N, Yoshizaki K, Shimoyama T and Kishimoto T: A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 126: 989-996, 2004.
24. Ito H, Hirotani T, Yamamoto M, Ogawa H and Kishimoto T: Anti-IL-6 receptor monoclonal antibody inhibits leukocyte recruitment and promotes T-cell apoptosis in a murine model of Crohn's disease. J Gastroenterol 37 (suppl 14): 56-61, 2002.
25. Ito H: Treatment of Crohn's disease with anti-IL-6 receptor antibody. J Gastroenterol 40 (suppl 16): 32-34, 2005.
26. Nagase H and Woessner JF Jr: Matrix metalloproteinases. J Biol Chem 274: 21491-21494, 1999.
27. Rouvier E, Luciani MF, Mattei MG, Denizot F and Golstein P: CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 150: 5445-5456, 1993.
28. Kolls JK and Linden A: Interleukin-17 family members and inflammation. Immunity 21: 467-476, 2004.
29. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK and Armitage RJ: Human IL-17: a novel cytokine derived from T cells. J Immunol 155: 5483-5486, 1995.
30. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Rouvier E, Golstein P, Banchereau J and Lebecque S: T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183: 2593-2603, 1996.
31. Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, Cohen JI and Spriggs MK: Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3: 811-821, 1995.
32. Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, Mineau F and Pelletier JP: IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 160: 3513-3521, 1998. (Pubitemid 28164746)
33. Kawaguchi M, Adachi M, Oda N, Kokubu F and Huang SK: IL-17 cytokine family. J Allergy Clin Immunol 114: 1265-1273, 2004.
34. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ and Suda T: IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103: 1345-1352, 1999.
35. Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H and Maslinski W: High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 164: 2832-2838, 2000.
36. Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, Alenius H, Dieu-Nosjean MC, Meller S, Rieker J, Steinhoff M, Hoffmann TK, Ruzicka T, Zlotnik A, Homey B: IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 117: 411-417, 2006.